133 related articles for article (PubMed ID: 18665467)
1. Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry.
Wu W; Wang R; Liu H; Peng J; Huang D; Li B; Ruan J
Med Oncol; 2009; 26(2):117-23. PubMed ID: 18665467
[TBL] [Abstract][Full Text] [Related]
2. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
[TBL] [Abstract][Full Text] [Related]
3. Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and its correlation with poor prognosis.
Gou X; Chen H; Jin F; Wu W; Li Y; Long J; Gong X; Luo M; Bi T; Li Z; He Q
Pathol Oncol Res; 2014 Apr; 20(2):475-81. PubMed ID: 24357157
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of CD147 and MMP-2
in squamous cell carcinoma and adenocarcinoma of the lungs].
Wang S; Li B; Wang S; Li Y; Li J
Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):710-4. PubMed ID: 21924036
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma.
Piao S; Zhao S; Guo F; Xue J; Yao G; Wei Z; Huang Q; Sun Y; Zhang B
J Cancer Res Clin Oncol; 2012 Apr; 138(4):627-35. PubMed ID: 22215147
[TBL] [Abstract][Full Text] [Related]
8. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients.
Zhao S; Ma W; Zhang M; Tang D; Shi Q; Xu S; Zhang X; Liu Y; Song Y; Liu L; Zhang Q
Med Oncol; 2013 Mar; 30(1):335. PubMed ID: 23263825
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases in gallbladder carcinoma and their significance in carcinogenesis.
Karadag N; Kirimlioglu H; Isik B; Yilmaz S; Kirimlioglu V
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):148-52. PubMed ID: 18227728
[TBL] [Abstract][Full Text] [Related]
10. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
11. Tumor-enhancing activity of Basigin expression in gallbladder carcinoma and its prognostic role.
Xiao GF; Tang HH
Mol Med Rep; 2009; 2(3):503-8. PubMed ID: 21475857
[TBL] [Abstract][Full Text] [Related]
12. Expression of MMP-2,TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance.
Fan YZ; Zhang JT; Yang HC; Yang YQ
World J Gastroenterol; 2002 Dec; 8(6):1138-43. PubMed ID: 12439941
[TBL] [Abstract][Full Text] [Related]
13. Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.
Quan ZW; Wu K; Wang J; Shi W; Zhang Z; Merrell RC
J Am Coll Surg; 2001 Oct; 193(4):380-3. PubMed ID: 11584965
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance].
Gou XX; Jin F; Chen HX; Wu WL; Chen L; Zeng Y
Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1264-7. PubMed ID: 20646600
[TBL] [Abstract][Full Text] [Related]
15. [Expression of CD147, matrix metalloproteinases and transforming growth factor beta1 in breast cancer].
Xue S; Li SX; Wu ZS; Wang XN; Wu Q; Yang F
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):524-8. PubMed ID: 20021962
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
17. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
18. Expression of Matrix Metalloproteinase-2, Tissue Inhibitor of Matrix Metalloproteinase-2 and CD147 in the Traditional Chinese Medicine "Compound T11" for Treatment of Chronic Liver Injury.
Xu H; Yang N; Zhang Z; Niu C; Yang W; Song J; Zhang J; Chen X; Jia Y; Miao Y
Pharmacology; 2019; 103(3-4):128-135. PubMed ID: 30544104
[TBL] [Abstract][Full Text] [Related]
19. Effects of matrix metalloproteinase inhibitor doxycycline and CD147 antagonist peptide-9 on gallbladder carcinoma cell lines.
Wang S; Liu C; Liu X; He Y; Shen D; Luo Q; Dong Y; Dong H; Pang Z
Tumour Biol; 2017 Oct; 39(10):1010428317718192. PubMed ID: 29034777
[TBL] [Abstract][Full Text] [Related]
20. Epithelial expression of extracellular matrix metalloproteinase inducer/CD147 and matrix metalloproteinase-2 in neoplasms and precursor lesions derived from cutaneous squamous cells: An immunohistochemical study.
Ayva SK; Karabulut AA; Akatli AN; Atasoy P; Bozdogan O
Pathol Res Pract; 2013 Oct; 209(10):627-34. PubMed ID: 23948694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
